Cargando…

Development and validation of 21-item outcome inventory (OI-21)

BACKGROUND: Outcome measurement is important for monitoring patients’ progress. The study aimed to develop an outcome inventory (OI) for clinical use in routine practice in psychiatric services and to examine the psychometric properties of the newly developed OI. METHODS: 48 items measuring anxiety,...

Descripción completa

Detalles Bibliográficos
Autores principales: Wongpakaran, Nahathai, Wongpakaran, Tinakon, Kövi, Zsuzsanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9193908/
https://www.ncbi.nlm.nih.gov/pubmed/35711988
http://dx.doi.org/10.1016/j.heliyon.2022.e09682
_version_ 1784726584792449024
author Wongpakaran, Nahathai
Wongpakaran, Tinakon
Kövi, Zsuzsanna
author_facet Wongpakaran, Nahathai
Wongpakaran, Tinakon
Kövi, Zsuzsanna
author_sort Wongpakaran, Nahathai
collection PubMed
description BACKGROUND: Outcome measurement is important for monitoring patients’ progress. The study aimed to develop an outcome inventory (OI) for clinical use in routine practice in psychiatric services and to examine the psychometric properties of the newly developed OI. METHODS: 48 items measuring anxiety, depression, interpersonal difficulties, and somatization were collected. Factor analysis was used to reduce the number of items. The final OI consisting of 21 items was then examined for psychometric properties among 1302 participants, 880 were nonclinical and 422 clinical patients. Tests included confirmatory factor analysis, internal consistency, test-retest reliability, convergent and discriminant validity, and diagnostic ability for major depression. Responsiveness was compared between baseline and 3-month follow-up. RESULTS: Confirmatory factor analysis revealed the OI-21 demonstrated the designated four components. Cronbach's alpha was good to excellent for all subjects with good test-retest reliability, concurrent validity, convergent and discriminant validity. It demonstrated area under the ROC curve of 0.89 indicating good diagnostic performance. Sensitivity to change after 3 months was observed in both types of treatment. However, interpersonal difficulties were sensitive to change in those receiving additional psychotherapy. CONCLUSION: OI-21 demonstrated its validity, reliability, and sensitivity to change. It constitutes a promising tool for outcome assessment in nonclinical populations and among psychiatric patients.
format Online
Article
Text
id pubmed-9193908
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-91939082022-06-15 Development and validation of 21-item outcome inventory (OI-21) Wongpakaran, Nahathai Wongpakaran, Tinakon Kövi, Zsuzsanna Heliyon Research Article BACKGROUND: Outcome measurement is important for monitoring patients’ progress. The study aimed to develop an outcome inventory (OI) for clinical use in routine practice in psychiatric services and to examine the psychometric properties of the newly developed OI. METHODS: 48 items measuring anxiety, depression, interpersonal difficulties, and somatization were collected. Factor analysis was used to reduce the number of items. The final OI consisting of 21 items was then examined for psychometric properties among 1302 participants, 880 were nonclinical and 422 clinical patients. Tests included confirmatory factor analysis, internal consistency, test-retest reliability, convergent and discriminant validity, and diagnostic ability for major depression. Responsiveness was compared between baseline and 3-month follow-up. RESULTS: Confirmatory factor analysis revealed the OI-21 demonstrated the designated four components. Cronbach's alpha was good to excellent for all subjects with good test-retest reliability, concurrent validity, convergent and discriminant validity. It demonstrated area under the ROC curve of 0.89 indicating good diagnostic performance. Sensitivity to change after 3 months was observed in both types of treatment. However, interpersonal difficulties were sensitive to change in those receiving additional psychotherapy. CONCLUSION: OI-21 demonstrated its validity, reliability, and sensitivity to change. It constitutes a promising tool for outcome assessment in nonclinical populations and among psychiatric patients. Elsevier 2022-06-07 /pmc/articles/PMC9193908/ /pubmed/35711988 http://dx.doi.org/10.1016/j.heliyon.2022.e09682 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Article
Wongpakaran, Nahathai
Wongpakaran, Tinakon
Kövi, Zsuzsanna
Development and validation of 21-item outcome inventory (OI-21)
title Development and validation of 21-item outcome inventory (OI-21)
title_full Development and validation of 21-item outcome inventory (OI-21)
title_fullStr Development and validation of 21-item outcome inventory (OI-21)
title_full_unstemmed Development and validation of 21-item outcome inventory (OI-21)
title_short Development and validation of 21-item outcome inventory (OI-21)
title_sort development and validation of 21-item outcome inventory (oi-21)
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9193908/
https://www.ncbi.nlm.nih.gov/pubmed/35711988
http://dx.doi.org/10.1016/j.heliyon.2022.e09682
work_keys_str_mv AT wongpakarannahathai developmentandvalidationof21itemoutcomeinventoryoi21
AT wongpakarantinakon developmentandvalidationof21itemoutcomeinventoryoi21
AT kovizsuzsanna developmentandvalidationof21itemoutcomeinventoryoi21